A Proactive Response to Prescription Opioid Abuse.
The FDA has committed to working with other agencies, health care providers, industry, and patients and families to deal proactively with the opioid abuse crisis, while safeguarding appropriate access to vitally important pain medications for the patients who need them.
The New England journal of medicine